Wonderful publicity for AVR and DurAVR.
It would be reasonable to expect that by the time the DurAVR gets to market a very high % of the world's top interventional cardiologists will be aware of its amazing results and competitive advantages and there will be an onslaught of these specialists wanting to purchase and use the DurAVR. This will create its own set of unique problems and hurdles for Mr Paterson and the management team.... if we ever get to that stage. I have my doubts.
Very exciting times ahead!
FIH 12 mth results published in Heart Lung Circulation, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.00 |
Change
0.000(0.00%) |
Mkt cap ! $93.76M | |||
| Open | High | Low | Value | Volume |
| $6.00 | $6.06 | $6.00 | $12.03K | 1.993K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 342 | $5.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.14 | 3138 | 2 |
View Market Depth
| Last trade - 11.06am 24/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |